Li, M., Li, Q., Zhang, Y., Xu, C., Chen, Z., Huang, Y., & Jiang, L. Cost-effectiveness of polatuzumab vedotin plus chemoimmunotherapy for untreated diffuse large B-cell lymphoma in China. Nature Portfolio.
Chicago Style (17th ed.) CitationLi, Mengya, Qian Li, Yinhui Zhang, Changjing Xu, Zhu Chen, Yilan Huang, and Longyang Jiang. Cost-effectiveness of Polatuzumab Vedotin Plus Chemoimmunotherapy for Untreated Diffuse Large B-cell Lymphoma in China. Nature Portfolio.
MLA (9th ed.) CitationLi, Mengya, et al. Cost-effectiveness of Polatuzumab Vedotin Plus Chemoimmunotherapy for Untreated Diffuse Large B-cell Lymphoma in China. Nature Portfolio.
Warning: These citations may not always be 100% accurate.